Susceptibility of Campylobacter Pyloridis to 20 Antimicrobial Agents

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1986 Sep 1

PMID 3777915

Citations 31

Authors

T Lambert

F Megraud

G Gerbaud

P Courvalin

Affiliations

Soon will be listed here.

Abstract

The susceptibility of 50 strains of Campylobacter pyloridis, isolated from human gastric biopsies, to 20 antimicrobial agents representing the different families of antibiotics was tested. The pattern of susceptibility was similar to that of the C. jejuni-C. coli group except for ampicillin, cephalothin, and rifampin. The relative resistance to cefsulodin was also noted.

Citing Articles

Helicobacter pylori detection and antimicrobial susceptibility testing.

Megraud F, Lehours P Clin Microbiol Rev. 2007; 20(2):280-322.

PMID: 17428887 PMC: 1865594. DOI: 10.1128/CMR.00033-06.

Direct and indirect methods of measuring Helicobacter pylori drug susceptibility in vitro.

McLaren A Mol Biotechnol. 2000; 13(3):247-55.

PMID: 10934536 DOI: 10.1385/MB:13:3:247.

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study.

Megraud F, Lehn N, Lind T, Bayerdorffer E, OMorain C, Spiller R Antimicrob Agents Chemother. 1999; 43(11):2747-52.

PMID: 10543758 PMC: 89554. DOI: 10.1128/AAC.43.11.2747.

In vitro and in vivo activities of tea catechins against Helicobacter pylori.

Mabe K, Yamada M, Oguni I, Takahashi T Antimicrob Agents Chemother. 1999; 43(7):1788-91.

PMID: 10390246 PMC: 89367. DOI: 10.1128/AAC.43.7.1788.

Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

Chaves S, Gadanho M, Tenreiro R, Cabrita J J Clin Microbiol. 1999; 37(5):1628-31.

PMID: 10203543 PMC: 84858. DOI: 10.1128/JCM.37.5.1628-1631.1999.

References

Marshall B, McGechie D, Rogers P, Glancy R . Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985; 142(8):439-44. DOI: 10.5694/j.1326-5377.1985.tb113444.x. View

Goodwin C, Blincow E, Warren J, WATERS T, Sanderson C, Easton L . Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol. 1985; 38(10):1127-31. PMC: 499453. DOI: 10.1136/jcp.38.10.1127. View

Megraud F, Bonnet F, Garnier M, Lamouliatte H . Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content. J Clin Microbiol. 1985; 22(6):1007-10. PMC: 271867. DOI: 10.1128/jcm.22.6.1007-1010.1985. View

Lambert T, Gerbaud G, Trieu-Cuot P, Courvalin P . Structural relationship between the genes encoding 3'-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol (1985). 1985; 136B(2):135-50. DOI: 10.1016/s0769-2609(85)80040-5. View

McNulty C, Dent J, Wise R . Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother. 1985; 28(6):837-8. PMC: 180341. DOI: 10.1128/AAC.28.6.837. View

Elharrif Z, Megraud F, MARCHAND A . Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother. 1985; 28(5):695-7. PMC: 176361. DOI: 10.1128/AAC.28.5.695. View

Taylor D, Ng L, Lior H . Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother. 1985; 28(5):708-10. PMC: 176366. DOI: 10.1128/AAC.28.5.708. View

Flores B, Fennell C, Holmes K, Stamm W . In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother. 1985; 28(2):188-91. PMC: 180216. DOI: 10.1128/AAC.28.2.188. View

SKIRROW M . Campylobacter enteritis: a "new" disease. Br Med J. 1977; 2(6078):9-11. PMC: 1631297. DOI: 10.1136/bmj.2.6078.9. View

10.

McNulty C, Watson D . Spiral bacteria of the gastric antrum. Lancet. 1984; 1(8385):1068-9. DOI: 10.1016/s0140-6736(84)91469-7. View

11.

Eldridge J, Lessells A, Jones D . Antibody to spiral organisms on gastric mucosa. Lancet. 1984; 1(8388):1237. DOI: 10.1016/s0140-6736(84)91716-1. View

12.

Marshall B, Warren J . Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1(8390):1311-5. DOI: 10.1016/s0140-6736(84)91816-6. View

13.

. Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet. 1984; 1(8390):1348-9. View

14.

Marshall B, McGechie D, Francis G, Utley P . Pyloric campylobacter serology. Lancet. 1984; 2(8397):281. DOI: 10.1016/s0140-6736(84)90318-0. View

15.

Kasper G, Dickgiesser N . Antibiotic sensitivity of "Campylobacter pylori". Eur J Clin Microbiol. 1984; 3(5):444. DOI: 10.1007/BF02017370. View

16.

Corbel M, Ibrahim M, Gill K . Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin. Vet Rec. 1984; 115(18):465. DOI: 10.1136/vr.115.18.465. View

17.

Kaldor J, Tee W, McCarthy P, Watson J, Dwyer B . Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet. 1985; 1(8434):921. DOI: 10.1016/s0140-6736(85)91687-3. View

18.

Marshall B, Armstrong J, McGechie D, Glancy R . Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985; 142(8):436-9. DOI: 10.5694/j.1326-5377.1985.tb113443.x. View